TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004
TCL Archive OMB Backs Down, Releases New Construction Funds After Ruling They Are “Alteration, Renovation” December 13, 1974
TCL Archive DeVita Says He Did Not Agree To Include “Chop-Like” Elements In CCOP RFA But That He Would Consider It March 19, 1982
